tiprankstipranks
Trending News
More News >
Clinica Baviera, SA (ES:CBAV)
BME:CBAV
Spanish Market

Clinica Baviera (CBAV) Ratios

Compare
8 Followers

Clinica Baviera Ratios

ES:CBAV's free cash flow for Q4 2025 was €1.00. For the 2025 fiscal year, ES:CBAV's free cash flow was decreased by € and operating cash flow was €0.23. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.26 1.26 0.95 1.28 1.09
Quick Ratio
1.26 1.26 0.88 1.22 1.03
Cash Ratio
1.07 1.07 0.20 0.18 0.47
Solvency Ratio
0.49 0.49 0.54 0.61 0.54
Operating Cash Flow Ratio
1.63 1.63 1.24 1.28 1.30
Short-Term Operating Cash Flow Coverage
0.00 0.00 31.17 28.69 26.60
Net Current Asset Value
€ -77.41M€ -77.41M€ -65.61M€ -28.63M€ -37.13M
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.28 0.30 0.27 0.32
Debt-to-Equity Ratio
0.63 0.63 0.65 0.52 0.71
Debt-to-Capital Ratio
0.39 0.39 0.40 0.34 0.42
Long-Term Debt-to-Capital Ratio
0.07 0.07 0.07 <0.01 0.04
Financial Leverage Ratio
2.25 2.25 2.19 1.96 2.23
Debt Service Coverage Ratio
157.01 157.01 19.58 20.99 18.81
Interest Coverage Ratio
141.13 141.13 45.75 87.49 99.07
Debt to Market Cap
<0.01 <0.01 0.02 <0.01 0.02
Interest Debt Per Share
3.86 4.18 3.97 2.95 2.96
Net Debt to EBITDA
0.22 0.22 0.68 0.58 0.51
Profitability Margins
Gross Profit Margin
81.24%20.06%88.36%87.96%87.15%
EBIT Margin
20.06%20.06%21.78%22.33%20.71%
EBITDA Margin
28.01%28.01%29.74%29.89%28.30%
Operating Profit Margin
20.06%20.06%21.20%22.24%20.91%
Pretax Profit Margin
19.92%19.92%21.32%22.08%20.50%
Net Profit Margin
14.23%14.23%15.31%15.99%14.87%
Continuous Operations Profit Margin
14.23%14.23%15.67%16.33%15.22%
Net Income Per EBT
71.43%71.43%71.81%72.44%72.56%
EBT Per EBIT
99.29%99.29%100.57%99.28%98.04%
Return on Assets (ROA)
17.35%17.35%18.97%20.14%19.67%
Return on Equity (ROE)
42.17%39.04%41.48%39.53%43.83%
Return on Capital Employed (ROCE)
30.20%30.20%34.53%37.50%38.04%
Return on Invested Capital (ROIC)
21.57%21.57%23.70%25.69%25.86%
Return on Tangible Assets
20.70%20.70%22.99%22.30%21.86%
Earnings Yield
4.81%5.19%7.92%9.61%10.38%
Efficiency Ratios
Receivables Turnover
34.24 34.24 54.55 63.15 69.78
Payables Turnover
2.24 9.53 3.04 1.74 1.63
Inventory Turnover
0.00 0.00 9.31 10.95 11.80
Fixed Asset Turnover
2.12 2.12 2.14 2.27 2.31
Asset Turnover
1.22 1.22 1.24 1.26 1.32
Working Capital Turnover Ratio
19.77 64.11 53.84 28.04 63.29
Cash Conversion Cycle
-152.56 -27.63 -74.26 -170.17 -187.43
Days of Sales Outstanding
10.66 10.66 6.69 5.78 5.23
Days of Inventory Outstanding
0.00 0.00 39.20 33.35 30.94
Days of Payables Outstanding
163.22 38.30 120.16 209.29 223.59
Operating Cycle
10.66 10.66 45.90 39.13 36.17
Cash Flow Ratios
Operating Cash Flow Per Share
4.25 4.60 3.86 3.55 3.27
Free Cash Flow Per Share
2.58 2.79 2.23 2.16 2.41
CapEx Per Share
1.67 1.80 1.63 1.39 0.86
Free Cash Flow to Operating Cash Flow
0.61 0.61 0.58 0.61 0.74
Dividend Paid and CapEx Coverage Ratio
1.36 1.36 1.20 1.62 1.71
Capital Expenditure Coverage Ratio
2.55 2.55 2.37 2.55 3.80
Operating Cash Flow Coverage Ratio
1.11 1.11 0.99 1.22 1.12
Operating Cash Flow to Sales Ratio
0.25 0.25 0.24 0.26 0.27
Free Cash Flow Yield
5.85%5.62%7.14%9.39%13.83%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.81 19.26 12.63 10.41 9.64
Price-to-Sales (P/S) Ratio
2.63 2.74 1.93 1.66 1.43
Price-to-Book (P/B) Ratio
8.12 7.52 5.24 4.11 4.22
Price-to-Free Cash Flow (P/FCF) Ratio
17.09 17.80 14.01 10.66 7.23
Price-to-Operating Cash Flow Ratio
11.68 10.81 8.09 6.48 5.33
Price-to-Earnings Growth (PEG) Ratio
10.49 4.33 1.07 0.47 1.25
Price-to-Fair Value
8.12 7.52 5.24 4.11 4.22
Enterprise Value Multiple
9.62 10.01 7.18 6.15 5.58
Enterprise Value
813.04M 845.99M 561.18M 413.47M 313.13M
EV to EBITDA
9.62 10.01 7.18 6.15 5.58
EV to Sales
2.69 2.80 2.14 1.84 1.58
EV to Free Cash Flow
17.49 18.20 15.48 11.77 7.96
EV to Operating Cash Flow
10.63 11.06 8.94 7.15 5.87
Tangible Book Value Per Share
3.93 4.26 3.77 4.60 3.27
Shareholders’ Equity Per Share
6.11 6.61 5.95 5.59 4.13
Tax and Other Ratios
Effective Tax Rate
0.29 0.29 0.27 0.26 0.26
Revenue Per Share
16.75 18.13 16.14 13.82 12.17
Net Income Per Share
2.38 2.58 2.47 2.21 1.81
Tax Burden
0.71 0.71 0.72 0.72 0.73
Interest Burden
0.99 0.99 0.98 0.99 0.99
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.09 0.07 0.09
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.38 1.78 1.12 1.61 1.31
Currency in EUR